Riverhead Capital Management’s Health Catalyst HCAT Stock Holding History

Riverhead Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$202K	Buy	+6,384	New	+$251K	0.01%	1130

Other funds holding HCAT

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Riverhead Capital Management's HCAT Position: Q3 2019 in Review

Riverhead Capital Management opened a new position in Health Catalyst (HCAT) in Q3 2019: 6,384 shares worth $202K. The stake represents 0.01% of the portfolio and ranks #1130 among its holdings.

86 funds tracked by Wall St. Rank hold HCAT as of Q3 2019.

Riverhead Capital Management held 6,384 shares of Health Catalyst worth $202K as of Q3 2019.
Health Catalyst was a new Riverhead Capital Management position in Q3 2019.
Health Catalyst made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1130 holding.
86 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.